Roles for PTK7 in cancer cell invasion have been reported in several clinical and experimental studies,15, 16, 17 suggesting that PTK7 represents a potential therapeutic target in advanced‐stage type 2 PRCC. The gene discussed is PTK7; the disease is cancer.